CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article


Fig. 5. Effect of PD098059 on cellular proliferation and MAP kinase phosphorylation. A, nonmalignant and malignant mammary cell lines were plated at a density of 1 x 104 cells/cm2 in 3.5-cm dishes and incubated in complete growth medium supplemented with PD098059 or with DMSO as vehicle control. Duplicate dishes were counted after 3–4 days. The number of cells in PD098059-treated dishes was expressed as a percentage of the number of cells in the respective control dishes. Results from at least three separate experiments were used to calculate the mean; bars, SE. The Student’s t test was used to determine that growth in the first four malignant lines was significantly different when compared with each of the other nonmalignant and malignant cell lines. *, P < 0.05. B, cells plated at equivalent subconfluent densities were treated as in A. After 3 h of treatment, cell lysates were prepared with RIPA buffer, and 10 µg of lysate protein were fractionated by SDS-PAGE and immunoblotted with anti-phosphoERK1/ERK2. The membrane was stripped and reprobed with anti-ERK2 to confirm that equivalent amounts of protein were present.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation